```

[Federal Register Volume 89, Number 242 (Tuesday, December 17, 2024)]
[Notices]
[Page 102148]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29646]

[[Page 102148]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Solicitation of Nominations for Appointment to the Clinical 
Laboratory Improvement Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), within the Department 
of Health and Human Services (HHS), is seeking nominations for 
membership on the Clinical Laboratory Improvement Advisory Committee 
(CLIAC). CLIAC, consisting of up to 20 members including the Chair, 
represents a diverse membership across laboratory specialties, 
professional roles (laboratory management, technical specialists, 
physicians, nurses), and practice settings (academic, clinical, public 
health), and includes a consumer representative.

DATES: Nominations for membership on CLIAC must be received no later 
than July 1, 2025. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected].

FOR FURTHER INFORMATION CONTACT: Heather Stang, M.S., Senior Advisor 
for Clinical Laboratories, Division of Laboratory Systems, Office of 
Laboratory Systems and Response, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop H24-2, Atlanta, Georgia 
30329-4027. Telephone: (404) 498-2769; Email: [email protected].

SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who 
have the expertise and qualifications necessary to contribute to the 
accomplishment of the objectives of the Clinical Laboratory Improvement 
Advisory Committee (CLIAC). Nominees will be selected based on 
expertise in the fields of microbiology (including bacteriology, 
mycobacteriology, mycology, parasitology, and virology), immunology 
(including histocompatibility), chemistry, hematology, pathology 
(including histopathology and cytology), or genetic testing (including 
cytogenetics); from representatives in the fields of medical 
technology, bioinformatics, public health, and clinical practice; and 
from consumer representatives. Selection of members is based on 
candidates' qualifications to contribute to the accomplishment of CLIAC 
objectives (https://www.cdc.gov/cliac/php/about/index.html). Members 
may be invited to serve up to four-year terms.
    Department of Health and Human Services (HHS) policy stipulates 
that committee membership be balanced in terms of points of view 
represented and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on Federal workgroups or prior experience serving 
on a Federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees, requiring the filing of 
financial disclosure reports at the beginning of and annually during 
their terms. The Centers for Disease Control and Prevention (CDC) 
reviews potential candidates for CLIAC membership each year and 
provides a slate of nominees for consideration to the Secretary of HHS 
for final selection. HHS notifies selected candidates of their 
appointment near the start of the term in July or as soon as the HHS 
selection process is completed. Note that the need for different 
expertise varies from year to year and a candidate who is not selected 
in one year may be reconsidered in a subsequent year.
    Candidates should submit the following items:
     Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
     At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (e.g., CDC, National Institutes of 
Health, Food and Drug Administration).
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-29646 Filed 12-16-24; 8:45 am]
BILLING CODE 4163-18-P
```